Rivastigmine Improves Appetite by Increasing the Plasma Acyl/Des-Acyl Ghrelin Ratio and Cortisol in Alzheimer Disease

Conclusions: Our results suggest that compared with donepezil, rivastigmine has the advantage of improving appetite by increasing the acyl/des-acyl ghrelin ratio and cortisol level, thereby preventing weight loss.Dement Geriatr Cogn Disord Extra 2018;8:77 –84
Source: Dementia and Geriatric Cognitive Disorders Extra - Category: Geriatrics Source Type: research